Ubs Global Asset Management Americas »

Inhibrx Biosciences shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2025-12-31 $790 10 79.00
2025-09-30 $3.7k 110 33.68